Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting tumor-resident mast cells for effective anti-melanoma immune responses
Susanne Kaesler, Florian Wölbing, W. Kempf, et al.
JCI Insight (2019) Vol. 4, Iss. 19
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Mast Cells: A New Frontier for Cancer Immunotherapy
Jake Lichterman, Sangeetha M. Reddy
Cells (2021) Vol. 10, Iss. 6, pp. 1270-1270
Open Access | Times Cited: 107
Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma
Anran Zhang, Jinpo Yang, Chao Ma, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 84
Mast Cell–Tumor Interactions: Molecular Mechanisms of Recruitment, Intratumoral Communication and Potential Therapeutic Targets for Tumor Growth
Deisy Segura-Villalobos, Itzel G. Ramírez-Moreno, Magnolia Martínez-Aguilar, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 349-349
Open Access | Times Cited: 47
Few, but Efficient: The Role of Mast Cells in Breast Cancer and Other Solid Tumors
Maria Teresa Majorini, Mario P. Colombo, Daniele Lecis
Cancer Research (2022) Vol. 82, Iss. 8, pp. 1439-1447
Open Access | Times Cited: 43
Role of Mast Cells in Regulation of T Cell Responses in Experimental and Clinical Settings
Daniel Elieh Ali Komi, Korneel Grauwet
Clinical Reviews in Allergy & Immunology (2017) Vol. 54, Iss. 3, pp. 432-445
Closed Access | Times Cited: 72
Combination Strategies to Augment Immune Check Point Inhibitors Efficacy - Implications for Translational Research
Hrishi Varayathu, Vinu Sarathy, Beulah Elsa Thomas, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 55
A Novel Ferroptosis-Associated Gene Signature to Predict Prognosis in Patients with Uveal Melanoma
Huan Luo, Chao Ma
Diagnostics (2021) Vol. 11, Iss. 2, pp. 219-219
Open Access | Times Cited: 53
CXCL10 potentiates immune checkpoint blockade therapy in homologous recombination-deficient tumors
Zhiwen Shi, Jianfeng Shen, Junjun Qiu, et al.
Theranostics (2021) Vol. 11, Iss. 15, pp. 7175-7187
Open Access | Times Cited: 44
Mast cell marker gene signature in head and neck squamous cell carcinoma
Zhimou Cai, Bingjie Tang, Lin Chen, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 26
Focus on mast cells in the tumor microenvironment: Current knowledge and future directions
Saimeng Shi, Long‐Yun Ye, Xianjun Yu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1878, Iss. 1, pp. 188845-188845
Closed Access | Times Cited: 26
Innate Immune Cells in Melanoma: Implications for Immunotherapy
Marialuisa Trocchia, Annagioia Ventrici, Luca Modestino, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8523-8523
Open Access | Times Cited: 5
Frenemies in the Microenvironment: Harnessing Mast Cells for Cancer Immunotherapy
Roberta Sulsenti, Elena Jachetti
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1692-1692
Open Access | Times Cited: 12
Sphinganine recruits TLR4 adaptors in macrophages and promotes inflammation in murine models of sepsis and melanoma
Marvin Hering, Alaa Madi, Roger Sandhoff, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Mast cell - tumor cell interaction related gene and microRNA expression profiles in oral squamous cell carcinoma
Tatjana Khromov, Maren Sitte, Gabriela Salinas, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Mast Cells and Microbiome in Health and Disease
Vincenzo Papa, Federica Li Pomi, Mario Di Gioacchino, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access
BTG2-deficient mast cells remodel the tumor and tumor-draining lymph node microenvironment leading to chemotherapy resistance in breast cancer
Xiaoqian Zhang, Jiayi Wang, Ziyu Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Cancer Cells Resistance Shaping by Tumor Infiltrating Myeloid Cells
Marcin Domagala, Chloé Laplagne, Edouard Leveque, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 165-165
Open Access | Times Cited: 27
Mast Cells and Skin and Breast Cancers: A Complicated and Microenvironment-Dependent Role
Mark Robert Hanes, Carman A. Giacomantonio, Jean S. Marshall
Cells (2021) Vol. 10, Iss. 5, pp. 986-986
Open Access | Times Cited: 24
The Influence of the microbiome on the innate immune microenvironment of solid tumors
Angel Charles, Ryan M. Thomas
Neoplasia (2023) Vol. 37, pp. 100878-100878
Open Access | Times Cited: 8
Thymosin α1 protects from CTLA-4 intestinal immunopathology
Giorgia Renga, Marina Maria Bellet, Marilena Pariano, et al.
Life Science Alliance (2020) Vol. 3, Iss. 10, pp. e202000662-e202000662
Open Access | Times Cited: 21
PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistance to neoadjuvant immunotherapy in esophageal squamous cell carcinoma
Jianhua Liu, Hao Chen, Guibin Qiao, et al.
Cancer Immunology Immunotherapy (2022) Vol. 72, Iss. 4, pp. 881-893
Open Access | Times Cited: 13
Controversial role of mast cells in NSCLC tumor progression and angiogenesis
Vito Longo, Annamaria Catino, Michele Montrone, et al.
Thoracic Cancer (2022) Vol. 13, Iss. 21, pp. 2929-2934
Open Access | Times Cited: 12
Ferroptosis-related genes DUOX1 and HSD17B11 affect tumor microenvironment and predict overall survival of lung adenocarcinoma patients
Chunhui Wei, Lixia Li, Youping Qiao, et al.
Medicine (2024) Vol. 103, Iss. 22, pp. e38322-e38322
Open Access | Times Cited: 2
High-Dose Ascorbate in Combination with Anti-PD1 Checkpoint Inhibition as Treatment Option for Malignant Melanoma
Markus Burkard, Heike Niessner, Christian Leischner, et al.
Cells (2023) Vol. 12, Iss. 2, pp. 254-254
Open Access | Times Cited: 6
The emerging role of mast cells in skin cancers: involved cellular and molecular mechanisms
Daniel Elieh Ali Komi, Ahmad Jalili
International Journal of Dermatology (2021) Vol. 61, Iss. 7, pp. 792-803
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top